These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20392980)

  • 41. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.
    Leroi I; Michalon M
    Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probability of obsessive and compulsive symptoms in Huntington's disease.
    Beglinger LJ; Langbehn DR; Duff K; Stierman L; Black DW; Nehl C; Anderson K; Penziner E; Paulsen JS;
    Biol Psychiatry; 2007 Feb; 61(3):415-8. PubMed ID: 16839521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apathy is not depression in Huntington's disease.
    Naarding P; Janzing JG; Eling P; van der Werf S; Kremer B
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):266-70. PubMed ID: 19776305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Have we forgotten neurological diseases with psychological symptoms? Case study: Huntington's chorea].
    Strkalj-Ivezić S; Muzinić L
    Med Arh; 2006; 60(5):320-1. PubMed ID: 16944738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes.
    Thompson JC; Snowden JS; Craufurd D; Neary D
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):37-43. PubMed ID: 11884653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Examining Huntington's disease patient and informant concordance on frontally mediated behaviors.
    Hergert DC; Sanchez-Ramos J; Cimino CR
    J Clin Exp Neuropsychol; 2015; 37(9):981-7. PubMed ID: 26332177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects.
    Berrios GE; Wagle AC; Marková IS; Wagle SA; Rosser A; Hodges JR
    Acta Psychiatr Scand; 2002 Mar; 105(3):224-30. PubMed ID: 11939977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical periods of suicide risk in Huntington's disease.
    Paulsen JS; Hoth KF; Nehl C; Stierman L
    Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Juvenile Huntington's disease presenting as difficult-to-treat seizure and the first episode of psychosis.
    Chuo YP; Hou PH; Chan CH; Lin CC; Liao YC
    Gen Hosp Psychiatry; 2012; 34(4):436.e9-11. PubMed ID: 22460005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations".
    Mestre TA; van Duijn E; Davis AM; Bachoud-Lévi AC; Busse M; Anderson KE; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2017 Mar; 32(3):482. PubMed ID: 28256103
    [No Abstract]   [Full Text] [Related]  

  • 51. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease.
    Anderson KE; Louis ED; Stern Y; Marder KS
    Am J Psychiatry; 2001 May; 158(5):799-801. PubMed ID: 11329405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosis with Huntington's disease: role of antipsychotic medications.
    Ding J; Gadit AM
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25139915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of depression on working memory in presymptomatic Huntington's disease.
    Nehl C; Ready RE; Hamilton J; Paulsen JS
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):342-6. PubMed ID: 11514640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study.
    Madhusoodanan S; Brenner R; Moise D; Sindagi J; Brafman I
    Ann Clin Psychiatry; 1998 Sep; 10(3):117-20. PubMed ID: 9781475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
    Ishihara L; Oliveri D; Wild EJ
    Ann Clin Transl Neurol; 2021 Jan; 8(1):126-137. PubMed ID: 33217173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.
    Duff K; Paulsen JS; Beglinger LJ; Langbehn DR; Wang C; Stout JC; Ross CA; Aylward E; Carlozzi NE; Queller S;
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):196-207. PubMed ID: 20463114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease.
    Sellers J; Ridner SH; Claassen DO
    J Neuropsychiatry Clin Neurosci; 2020; 32(2):109-124. PubMed ID: 31466515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors predicting discharge of Huntington's disease patients from a neuropsychiatry unit.
    Vasudev A; Palmer T; Thomas A; Burn D; Barker W
    Int Psychogeriatr; 2010 May; 22(3):489-92. PubMed ID: 20085671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.